Amrutanjan Health Care Limited (IN:AMRUTANJAN)
:AMRUTANJAN
Want to see IN:AMRUTANJAN full AI Analyst Report?
AMRUTANJAN Stock Chart & Stats
₹671.50
-₹1.00(-0.14%)
At close: 4:00 PM EST
₹671.50
-₹1.00(-0.14%)
Day’s Range― - ―
52-Week Range₹490.00 - ₹789.95
Previous CloseN/A
Volume4.33K
Average Volume (3M)587.00
Market Cap
₹15.98B
Enterprise Value₹15.11B
Total Cash (Recent Filing)₹2.07B
Total Debt (Recent Filing)₹19.32M
Price to Earnings (P/E)27.3
Beta0.82
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.68%
Share Statistics
EPS (TTM)19.61
Shares Outstanding29,230,630
10 Day Avg. Volume607
30 Day Avg. Volume587
Financial Highlights & Ratios
PEG Ratio1.77
Price to Book (P/B)3.86
Price to Sales (P/S)2.84
P/FCF Ratio-458.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Conservative Balance SheetExtremely low leverage and a rising equity base materially reduce financial risk and preserve strategic optionality. Over the next 2–6 months this conservatism supports capital allocation flexibility, resilience to demand shocks, and the ability to fund working capital or targeted investment without stress.
Stable Profitability MarginsConsistent mid-teens-level operating profitability demonstrates sustainable core economics in its OTC portfolio. Stable margins indicate the business can absorb moderate cost variability while still producing predictable earnings, supporting reinvestment and dividend capacity over multiple quarters.
Established Branded OTC Business ModelA brand-led consumer healthcare model with established retail and distributor reach supports repeat purchase and pricing power in core categories. Durable consumer recognition and multi-channel distribution underpin steady demand and lower customer-acquisition costs versus newer entrants.
Bears Say
Weak Cash-generation ConsistencyRecent divergence between accounting profits and cash flow reduces financial predictability; negative FCF in 2026 suggests rising working-capital needs or higher investment. This undermines the balance sheet's practical liquidity and could constrain reinvestment or shareholder returns if persistent.
Margin Compression RiskA notable decline in gross and operating margins versus earlier years signals either cost inflation or pricing pressure. If structural, this erosion reduces cash generation ability and return on equity, forcing higher volume reliance or cost cuts to restore historic profitability levels.
Slowing Top-line GrowthA decelerating revenue trend weakens the company's ability to leverage fixed costs and sustain margin expansion. Slower growth may reflect competitive pressure or market saturation in core OTC categories, limiting medium-term earnings upside absent new product or channel expansion.
Amrutanjan Health Care Limited News
AMRUTANJAN FAQ
What was Amrutanjan Health Care Limited’s price range in the past 12 months?
Amrutanjan Health Care Limited lowest stock price was ₹490.00 and its highest was ₹789.95 in the past 12 months.
What is Amrutanjan Health Care Limited’s market cap?
Amrutanjan Health Care Limited’s market cap is ₹15.98B.
When is Amrutanjan Health Care Limited’s upcoming earnings report date?
Amrutanjan Health Care Limited’s upcoming earnings report date is Aug 10, 2026 which is in 50 days.
How were Amrutanjan Health Care Limited’s earnings last quarter?
Amrutanjan Health Care Limited released its earnings results on May 08, 2026. The company reported ₹5.6 earnings per share for the quarter, beating the consensus estimate of N/A by ₹5.6.
Is Amrutanjan Health Care Limited overvalued?
According to Wall Street analysts Amrutanjan Health Care Limited’s price is currently Overvalued.
Does Amrutanjan Health Care Limited pay dividends?
Amrutanjan Health Care Limited pays a Quarterly dividend of ₹1 which represents an annual dividend yield of 0.68%. See more information on Amrutanjan Health Care Limited dividends here
What is Amrutanjan Health Care Limited’s EPS estimate?
Amrutanjan Health Care Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amrutanjan Health Care Limited have?
Amrutanjan Health Care Limited has 29,230,630 shares outstanding.
What happened to Amrutanjan Health Care Limited’s price movement after its last earnings report?
Amrutanjan Health Care Limited reported an EPS of ₹5.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.754%.
Which hedge fund is a major shareholder of Amrutanjan Health Care Limited?
Currently, no hedge funds are holding shares in IN:AMRUTANJAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amrutanjan Health Care Limited
Established in Chennai, India, in 1893, Amrutanjan Health Care Limited, formerly known as Amrutanjan Limited until its renaming in 2007, is a prominent manufacturer, supplier, and vendor of a broad array of wellness products. The company primarily operates across its OTC Products, Beverages, and Others divisions. Its core offerings include ayurvedic pain relief balms, non-alcoholic drinks, and feminine hygiene products. For pain management, Amrutanjan provides a comprehensive range of solutions such as traditional pain balms, various roll-ons, back pain lotions, body pain gels, joint muscle sprays, and diclofenac-based remedies. To address congestion, the company offers cold rubs, cough syrups, nasal inhalers, and Swas Mints. Additionally, its product line features sanitary napkins for women, corn caps, and hand sanitizers. Within its beverage segment, it manufactures juice drinks marketed under the Fruitnik and Fruitnik Electro+ brand names. Amrutanjan also extends its services by operating a pain management center. The company's global presence is marked by product exports to the Middle East, Africa, Southeast Asia, and other international markets.
Technical Analysis
Indoco Remedies Limited
―
Krsnaa Diagnostics Limited
―
TTK Healthcare Limited
―
Zota Health Care Ltd.
―